/

Glaukos Corporation

6GJ GF

6GJ GFGlaukos Corporation

FIGI: BBG009J95TV7

72.00

EUR

+1.00

(+1.41%)

Glaukos Corporation

6GJ:GF

(FRANKFURT)

Recent

price

72.00

P/E

ratio

-27.26

div

yld

- -

ROIC.AI

Legends:

Stock price

0.46

Beta (1.0 Market)

% total return 09/21

Stock

S&P500

YTD

25.66

- -

82.05

- -

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

USD

- -

0.84

1.83

4.10

3.47

4.63

5.13

6.34

5.06

6.33

5.96

6.20

- -

-0.51

-0.49

-2.13

0.14

0.00

-0.37

0.41

-2.70

-1.07

-2.09

-2.64

- -

-0.57

-0.32

-0.18

0.18

0.56

0.24

-0.14

-0.67

-0.50

-1.34

-2.02

- -

-4.96

-5.36

-6.11

-5.66

-5.55

-5.68

-4.36

-6.85

-7.78

-9.72

-10.99

- -

-10.85

-11.17

2.64

3.26

3.90

4.82

5.16

5.38

4.01

3.27

2.63

- -

114

159

181

237

225

294

283

297

- -

-67.78

-28.89

-14.36

3.71

-1.43

-7.17

-21.22

-54.92

-21.38

-36.17

-39.56

- -

-13

-12

-37

-13

-120

-50

-99

-126

- -

0.94

9,300.00

- -

-60.34

-26.60

-51.94

3.95

-0.06

-7.14

6.51

-53.50

-16.87

-35.07

-42.61

- -

-10

103

123

146

205

420

423

372

337

- -

271

382

384

- -

-149

-161

117

138

174

673

667

587

530

489

- -

3.79

164.99

- -

-2.70

2.16

- -

Capital Structure

USD

•

in mil. unless spec.

Dec'22

Mar'23

Jun'23

ST Debt

- -

LT Borrowings

281

282

LT Finance Leases

101

102

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

2,086

2,402

3,445

Working Capital

USD

•

in mil. unless spec.

Dec'22

Mar'23

Jun'23

Total Current Assets

444

416

401

Cash, Cash Equivalents & STI

353

318

304

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

- -

Deferred Revenue

- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

0.00%

13.33%

-3.74%

Net Income, GAAP

-NaN%

-98.00%

Free Cash Flow

-NaN%

-171.75%

-173.91%

Total Cash Common Dividend

- -

Total Equity

-NaN%

58.05%

-9.71%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

2021

294

2022

283

2023

- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

2021

-0.36

-0.38

0.13

-0.47

-1.07

2022

0.11

-0.96

-0.58

-0.66

-2.09

2023

-0.72

-0.68

- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Business: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.

- -

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

USD

- -

0.84

1.83

4.10

3.47

4.63

5.13

6.34

5.06

6.33

5.96

6.20

- -

-0.51

-0.49

-2.13

0.14

0.00

-0.37

0.41

-2.70

-1.07

-2.09

-2.64

- -

-0.57

-0.32

-0.18

0.18

0.56

0.24

-0.14

-0.67

-0.50

-1.34

-2.02

- -

-4.96

-5.36

-6.11

-5.66

-5.55

-5.68

-4.36

-6.85

-7.78

-9.72

-10.99

- -

-10.85

-11.17

2.64

3.26

3.90

4.82

5.16

5.38

4.01

3.27

2.63

- -

114

159

181

237

225

294

283

297

- -

-67.78

-28.89

-14.36

3.71

-1.43

-7.17

-21.22

-54.92

-21.38

-36.17

-39.56

- -

-13

-12

-37

-13

-120

-50

-99

-126

- -

0.94

9,300.00

- -

-60.34

-26.60

-51.94

3.95

-0.06

-7.14

6.51

-53.50

-16.87

-35.07

-42.61

- -

-10

103

123

146

205

420

423

372

337

- -

271

382

384

- -

-149

-161

117

138

174

673

667

587

530

489

- -

3.79

164.99

- -

-2.70

2.16

- -